Novel compounds of the present invention are represented by the general formula (1) ##STR1## wherein R.sub.1 is hydrogen atom or amino, R.sub.2 is fluorine atom or methoxy, R.sub.3 is hydrogen atom or a lower alkyl having 1 to 3 carbon atoms, and n is 0 or 1. The compounds of the general formula (1) exhibit higher antibacterial activity with fewer side-effects than known quinolone antibiotics such as ofloxacin and norfloxacin. Further, the compounds having the general formula (1) have reduced phototoxicity which normally accompanies 6,8-defluoroquinoline antibiotics.
本发明的新化合物由一般式(1)表示:##STR1##其中R.sub.1是氢原子或
氨基,R.sub.2是
氟原子或甲氧基,R.sub.3是氢原子或具有1至3个碳原子的低碳基,n为0或1。一般式(1)化合物表现出比已知的喹诺
酮类抗生素如
氧氟沙星和
诺氟沙星更高的抗菌活性,副作用更少。此外,具有一般式(1)的化合物具有通常伴随着6,8-二
氟喹诺
酮类抗生素的光毒性降低的特性。